ProfileGDS5678 / 1419696_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 5% 5% 5% 81% 14% 5% 11% 5% 31% 5% 5% 5% 5% 5% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.066235
GSM967853U87-EV human glioblastoma xenograft - Control 22.050435
GSM967854U87-EV human glioblastoma xenograft - Control 32.064215
GSM967855U87-EV human glioblastoma xenograft - Control 45.9732981
GSM967856U87-EV human glioblastoma xenograft - Control 52.2962314
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.104615
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3062911
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.056655
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6878631
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.054185
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.046345
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.036225
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.055415
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.04585